Efficacy and Safety of the Neodymium Laser in Treatment of Urogenital Tract Diseases in Women

NCT05251220 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2022-02-22

No results posted yet for this study

Summary

Study objective: To evaluate the efficacy and safety of the Magic Max neodymium laser in the medical treatment of women with symptoms of genitourinary syndrome of menopausal, vulvar lichen sclerosus and pelvic floor muscle reduction.

Conditions

  • Genitourinary Syndrome of Menopause
  • Pelvic Floor Dysfunction
  • Vulvar Lichen Sclerosus

Sponsors & Collaborators

  • 1st Federal Budgetary Healthcare Institution Volga District Medical Center

    lead OTHER_GOV

Eligibility

Min Age
29 Years
Max Age
72 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2020-12-24
Completion
2020-12-24

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05251220 on ClinicalTrials.gov